Recent Developments to Cope the Antibacterial Resistance via β-Lactamase Inhibition

Recent Developments to Cope the Antibacterial Resistance via β-Lactamase Inhibition

Antibacterial resistance towards the β-lactam (BL) drugs is now ubiquitous, and there is a major global health concern associated with the emergence of new β-lactamases (BLAs) as the primary cause of resistance. In addition to the development of new antibacterial drugs, β-lactamase inhibition is an...

Full description

Bibliographic Details
Main Authors: Zafar Iqbal, Jian Sun, Haikang Yang, Jingwen Ji, Lili He, Lijuan Zhai, Jinbo Ji, Pengjuan Zhou, Dong Tang, Yangxiu Mu, Lin Wang, Zhixiang Yang
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Molecules
Subjects:
antibacterial resistance
β-lactamase inhibitor
diazabicyclooctane
boronic acids
avibactam
relebactam
Online Access:https://www.mdpi.com/1420-3049/27/12/3832

Internet

https://www.mdpi.com/1420-3049/27/12/3832

Similar Items